Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man

Journal of Clinical Psychopharmacology

Volumn 28, Issue 2, 2008, Pages 245-247

  Varkula, Mackenzie ^a   Dale, Roman ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; DIPHENHYDRAMINE; LORAZEPAM; QUETIAPINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; DYSTONIA; HUMAN; LABORATORY TEST; LETTER; MALE; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; DYSTONIA; HUMANS; MALE; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES;

EID: 40949127038     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31816740ad     Document Type: Letter

References (15)

1. Stahl S. Essential Psychopharmacology of Antipsychotics and Mood Stabilizers. Cambridge: Cambridge University Press; 2002.
2. Grunder G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry. 2003;60:974-977.
3. Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs. placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2003;60:681-690.
4. Marder SR, McQuade RD, Stock E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short term, placebo-controlled trials. Schizophr Res. 2003;61:123-136.
5. Schonberger RB, Douglas L, Baum CR. Severe extrapyramidal symptoms in a 3 year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole (letter). Pediatrics. 2004;114:1743.
6. Lindsey RL, Kaplan D, Koliatsos V, et al. Aripiprazole and extrapyramidal symptoms. J Am Acad Child Adolesc Psychiatry. 2003;42:1268-1269.
7. Fountoulakis K, Siamouli M, Kantartzis S, et al. Acute dystonia with low-dose aripiprazole in Tourette's disorder. Ann Pharmacother. 2006;40:775-777.
8. Desarkar P, Thakur A, Sinha V. Aripiprazole-induced acute dystonia. Am J Psychiatry. 2006;163:1112-1113.
9. Rota E, Bergesio G, Dettoni E, et al. Pisa syndrome during aripiprazole treatment: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:286-287.
10. Salmoiraghi A, Odiyoor M. A case of aripiprazole and extrapyrmidal side effects. J Psychopharmacol. 2006;20:592-593.
11. Van Harten PN, Hoek HW, Kahn RS. Acute dystonia induced by drug treatment. BMJ. 1999;319:623-626.
12. Keepers GA, Casey DE. Prediction of neuroleptic-induced dystonia. J Clin Psychopharmacol. 1987;7:342-345.
13. Aguilar EJ, Keshavan MS, Martinez-Quiles MD, et al. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry. 1994;151:1819-1821.
14. Aichhorn W, Whitworth AB, Weiss EM, et al. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf. 2006;29:587-598.
15. Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med. 1980;10:55-72.